More Than $3M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in Asana, Inc. (ASAN), AMREP Corporation (AXR), and Nuvectis Pharma, Inc. (NVCT). ASAN's CEO acquired 160,000 shares, indicating confidence in the company following better-than-expected Q1 results. AXR's 10% owner bought 25,361 shares after a sharp increase in Q3 EPS. NVCT's 10% owner purchased 8,948 shares as the company posted a narrower-than-expected quarterly loss.
July 11, 2023 | 1:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Asana's CEO purchased 160,000 shares, indicating confidence in the company's prospects.
The CEO's purchase of a significant number of shares indicates a strong belief in the company's future performance. This, combined with better-than-expected Q1 results, could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
AMREP's 10% owner bought 25,361 shares following a sharp increase in Q3 EPS.
The purchase by a 10% owner following a sharp increase in Q3 EPS indicates confidence in the company's financial health, which could positively impact the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Nuvectis Pharma's 10% owner purchased 8,948 shares as the company posted a narrower-than-expected quarterly loss.
The purchase by a 10% owner following a narrower-than-expected quarterly loss indicates confidence in the company's financial recovery, which could positively impact the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100